30:22

Vaccinations - Adverse Reactions

https://d360v0nslzk1hl.cloudfront.net/thumbnail_images/167/thumbnail_167_20200706020045.png?Expires=1770621119&Signature=VZsgsI5lfUM1aEksBSRd2EN3m~NvmxUYu-siY5txf4h2-0FPsngjX3hBu9~3rd87FhwGcDtRS48Bj21K~97t76~WiLbhOcmJWvXLiuvEkT3dZ8wT5uTBxGGzEZZ3BdscpNEi-g-0RDiC0X-7MPJ0V1KL77AgDRrN2whNB~ZB48NWzbkqkqlrAmnaEGf0R667CfnFmSHdbv-5GbCKEpxoIJZunKi6P5sJTPNZ3VjmnJnoR4K8MPzAIr634Vr5bdCCI7PlfCw3F-QF-WmYBUvLXtl4ugsIZ3kkG1phzUF9~Fbef96bxBSDWemkLR~7YquS3XbNbu0r2EFk-HZM6bI90g__&Key-Pair-Id=APKAJYRCU5335P523QIQ

Richard B. Ford, DVM, MS VetScope 2020-07-06

字幕未対応

スライド

関連動画

全て表示

p.1

p.1

WHEN VACCINATION GOES WRONG...
Adverse Reactions
Richard B. Ford, DVM, MS
North Carolina State University

p.1
p.2

p.2

Residual virulence of attenuated vaccine

Canine Hepatitis Virus (CAV-1) Vaccine

p.2
p.3

p.3

AAHA Canine Vaccination Guidelines

VACCINATION RECOMMENDATIONS Practice
RABIES VACCINATION (NEW)
OVERDUE for VACCINATION (NEW)
VACCINATION RECOMMENDATIONS Shelter-Housed Dogs
ANTIBODY TESTING vs VACCINATION (NEW)
LEGAL CONSIDERATIONS
VACCINE ADVERSE REACTIONS
VACCINE TYPES
VACCINE STORAGE & HANDLING (NEW)
THERAPEUTIC BIOLOGICS (NEW)
LICENSING of VACCINES
THE VACCINE LABEL (NEW)
FREQUENTLY ASKED QUESTIONS
REFERENCES and Appendices
LIFESTYLE FACTORS (NEW)

p.3
p.4

p.4

Vaccine Adverse Events
- Lumps and Lethargy and Transient Pain/Discomfort
- Failure to Immunize
- Hypersensitivity
- Type 1
- Type 2
- Type 3
- Type 4
- Tumorigenesis (VAS)
- Transient Immune Suppression
- Inappropriate Administration of Vaccine
- Residual Virulence of an Attenuated (MLV) Vaccine
- Vaccine-Induced Interference with Diagnostic Tests
- Multisystemic Inflammatory Disorder of Weimaraners
- Reversion to Virulence-MLV vaccine only (rare)

p.4
p.5

p.5

Vaccine Adverse Events
- Lumps and Lethargy and Transient Pain/Discomfort
- Failure to Immunize
- Hypersensitivity
- Type 1
- Type 2
- Type 3
- Type 4
- Tumorigenesis (VAS)
- Transient Immune Suppression
- Inappropriate Administration of Vaccine
- Residual Virulence of an Attenuated (MLV) Vaccine
- Vaccine-Induced Interference with Diagnostic Tests
- Multisystemic Inflammatory Disorder of Weimaraners
- Reversion to Virulence-MLV vaccine only (rare)

p.5
p.6

p.6

Vaccine Adverse Events
- Lumps and Lethargy and Transient Pain/Discomfort
- Failure to Immunize
- Hypersensitivity
- Type 1
- Type 2
- Type 3
- Type 4
- Tumorigenesis (VAS)
- Transient Immune Suppression
- Inappropriate Administration of Vaccine
- Residual Virulence of an Attenuated (MLV) Vaccine
- Vaccine-Induced Interference with Diagnostic Tests
- Multisystemic Inflammatory Disorder of Weimaraners
- Reversion to Virulence-MLV vaccine only (rare)

p.6
p.7

p.7

#1 Cause: Failure to Immunize

Maternally Derived Antibody

p.7
p.8

p.8

Maternal Antibody Interference
“window of susceptibility”

MLV Vaccines (distemper, parvovirus, adenovirus)

Titer

8 wk 12 wk 16 wk

p.8
p.9

p.9

Vaccine Adverse Events
- Lumps and Lethargy and Transient Pain/Discomfort
- Failure to Immunize
- Hypersensitivity
- Type 1
- Type 2
- Type 3
- Type 4
Tumorigenesis (VAS)
Transient Immune Suppression
Inappropriate Administration of Vaccine
Residual Virulence of an Attenuated (MLV) Vaccine
Vaccine-Induced Interference with Diagnostic Tests
Multisystemic Inflammatory Disorder of Weimaraners
Reversion to Virulence-MLV vaccine only (rare)

p.9
p.10

p.10

Angioedema

p.10
p.11

p.11

Acute Hypersensitivity Reactions

KILLED
MODIFIED-LIVE
RECOMBINANT
‘Naked’ DNA

p.11
p.12

p.12

Killed (inactivated) Vaccine

p.12
p.13

p.13

To Prevent:

Diphenhydramine
2-4 mg/kg, oral, ~30 minutes prior

Corticosteroids AND Vaccine at the same time???

To Treat:
Prednisolone
0.5-1.0 mg/kg, SQ or IM

p.13
p.14

p.14

IMAGE

p.14
p.15

p.15

IMAGE

p.15
p.16

p.16

Considerations for vaccinating small breed dogs...
(<= 10 kg estimated adult wgt)

CONSIDER...
...administering NON-CORE vaccines 2-weeks after completion of the initial CORE vaccine series.

p.16
p.17

p.17

Vaccine Adverse Events
Lumps and Lethargy and Transient Pain/Discomfort
- Failure to Immunize
- Hypersensitivity
- Type 1
- Type 2
- Type 3
- Type 4
Tumorigenesis (VAS)
Transient Immune Suppression
Inappropriate Administration of Vaccine
Residual Virulence of an Attenuated (MLV) Vaccine
Vaccine-Induced Interference with Diagnostic Tests
Multisystemic Inflammatory Disorder of Weimaraners
Reversion to Virulence-MLV vaccine only (rare)

p.17
p.18

p.18

IMAGE

p.18
p.19

p.19

Immune-Mediated
Hemolytic Anemia
-or-
Vaccine-Induced (?)
-or-
Infectious
-or-
Neoplasia
-or-
Drug-associated

Agglutination in Anticoagulated Blood (EDTA)

p.19
p.20

p.20

Vaccine Adverse Events
Lumps and Lethargy and Transient Pain/Discomfort
- Failure to Immunize
- Hypersensitivity
- Type 1
- Type 2
- Type 3
- Type 4
- Tumorigenesis (VAS)
-Transient Immune Suppression
- Inappropriate Administration of Vaccine
- Residual Virulence of an Attenuated (MLV) Vaccine
- Vaccine-Induced Interference with Diagnostic Tests
- Multisystemic Inflammatory Disorder of Weimaraners
- Reversion to Virulence-MLV vaccine only (rare)

p.20
p.21

p.21

Rabies Vaccine-Associated Ischemic Vasculitis

p.21
p.22

p.22

IMAGE

p.22
p.23

p.23

Post-Vaccination Vasculitis

p.23
p.24

p.24

IMAGE

p.24
p.25

p.25

Intranasal Bordetella
Injected SQ

p.25

00:36:01

Initial Vaccination Protocol

Richard B. Ford, DVM, MS

VetScope

コンテンツの閲覧にはログインが必要です

アカウントをお持ちでない方はこちら